Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy
- PMID: 30177372
- DOI: 10.1016/j.radonc.2018.07.027
Texture analysis of 3D dose distributions for predictive modelling of toxicity rates in radiotherapy
Abstract
Background and purpose: To explore the use of texture analysis (TA) features of patients' 3D dose distributions to improve prediction modelling of treatment complication rates in prostate cancer radiotherapy.
Material and methods: Late toxicity scores, dose distributions, and non-treatment related (NTR) predictors for late toxicity, such as age and baseline symptoms, of 351 patients of the hypofractionation arm of the HYPRO randomized trial were used in this study. Apart from DVH parameters, also TA features of rectum and bladder 3D dose distributions were used for predictive modelling of gastrointestinal (GI) and genitourinary (GU) toxicities. Logistic Normal Tissue Complication Probability (NTCP) models were derived, using only NTR parameters, NTR + DVH, NTR + TA, and NTR + DVH + TA.
Results: For rectal bleeding, the area under the curve (AUC) for using only NTR parameters was 0.58, which increased to 0.68, and 0.73, when adding DVH or TA parameters respectively. For faecal incontinence, the AUC went up from 0.63 (NTR only), to 0.68 (+DVH) and 0.73 (+TA). For nocturia, adding TA features resulted in an AUC increase from 0.64 to 0.66, while no improvement was seen when including DVH parameters in the modelling. For urinary incontinence, the AUC improved from 0.68 to 0.71 (+DVH) and 0.73 (+TA). For GI, model improvements resulting from adding TA parameters to NTR instead of DVH were statistically significant (p < 0.04).
Conclusion: Inclusion of 3D dosimetric texture analysis features in predictive modelling of GI and GU toxicity rates in prostate cancer radiotherapy improved prediction performance, which was statistically significant for GI.
Keywords: 3D dose distribution; Dosiomics; NTCP predictive modelling; Prostate radiotherapy; Radiomics; Texture analysis.
Copyright © 2018 Elsevier B.V. All rights reserved.
Similar articles
-
Tolerance doses for late adverse events after hypofractionated radiotherapy for prostate cancer on trial NRG Oncology/RTOG 0415.Radiother Oncol. 2019 Jun;135:19-24. doi: 10.1016/j.radonc.2019.02.014. Epub 2019 Mar 5. Radiother Oncol. 2019. PMID: 31015166 Free PMC article.
-
Late toxicity after intensity-modulated radiation therapy for localized prostate cancer: an exploration of dose-volume histogram parameters to limit genitourinary and gastrointestinal toxicity.Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):235-41. doi: 10.1016/j.ijrobp.2010.09.058. Epub 2010 Dec 14. Int J Radiat Oncol Biol Phys. 2012. PMID: 21163587
-
Radiomics Analysis of 3D Dose Distributions to Predict Toxicity of Radiotherapy for Cervical Cancer.J Pers Med. 2021 May 11;11(5):398. doi: 10.3390/jpm11050398. J Pers Med. 2021. PMID: 34064918 Free PMC article.
-
A Systematic Post-QUANTEC Review of Tolerance Doses for Late Toxicity After Prostate Cancer Radiation Therapy.Int J Radiat Oncol Biol Phys. 2018 Dec 1;102(5):1514-1532. doi: 10.1016/j.ijrobp.2018.08.015. Epub 2018 Aug 17. Int J Radiat Oncol Biol Phys. 2018. PMID: 30125635 Free PMC article.
-
Pelvic Complications After Prostate Cancer Radiation Therapy and Their Management: An International Collaborative Narrative Review.Eur Urol. 2019 Mar;75(3):464-476. doi: 10.1016/j.eururo.2018.12.003. Epub 2018 Dec 17. Eur Urol. 2019. PMID: 30573316
Cited by
-
Dosiomics: Extracting 3D Spatial Features From Dose Distribution to Predict Incidence of Radiation Pneumonitis.Front Oncol. 2019 Apr 12;9:269. doi: 10.3389/fonc.2019.00269. eCollection 2019. Front Oncol. 2019. PMID: 31032229 Free PMC article.
-
Review of Radiomics- and Dosiomics-based Predicting Models for Rectal Cancer.Front Oncol. 2022 Aug 9;12:913683. doi: 10.3389/fonc.2022.913683. eCollection 2022. Front Oncol. 2022. PMID: 36016617 Free PMC article. Review.
-
Do Dosiomic Features Extracted From Planned 3-Dimensional Dose Distribution Improve Biochemical Failure-Free Survival Prediction: an Analysis Based on a Large Multi-Institutional Data Set.Adv Radiat Oncol. 2023 Mar 27;8(5):101227. doi: 10.1016/j.adro.2023.101227. eCollection 2023 Sep-Oct. Adv Radiat Oncol. 2023. PMID: 37216005 Free PMC article.
-
Interpretable machine learning for predicting pathologic complete response in patients treated with chemoradiation therapy for rectal adenocarcinoma.Front Artif Intell. 2022 Dec 7;5:1059033. doi: 10.3389/frai.2022.1059033. eCollection 2022. Front Artif Intell. 2022. PMID: 36568580 Free PMC article.
-
Development and Validation of a Radiomics Nomogram for Predicting Clinically Significant Prostate Cancer in PI-RADS 3 Lesions.Front Oncol. 2022 Jan 26;11:825429. doi: 10.3389/fonc.2021.825429. eCollection 2021. Front Oncol. 2022. PMID: 35155214 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical